A Starkey and MED-EL bimodal streaming partnership will enable Apple technology to seamlessly stream to compatible Starkey hearing aids and MED-EL cochlear implants.
The leading hearing technology companies said DualSync would bring together the strength of Starkey’s industry-leading hearing aids with the innovation behind MED-EL’s cochlear implants, “creating a seamless and unified wireless audio experience for people who rely on both technologies”.
DualSync technology provides seamless audio connectivity and synchronised sound from compatible smartphones and media devices, empowering users with more natural, connected hearing, they said.
Starting on July 1, 2025, Starkey Edge AI and Genesis AI hearing aids and MED-EL SONNET 3, SONNET 2, SONNET, and RONDO 3 audio processors will be compatible for bimodal streaming.
The solution is designed to support a growing ecosystem of devices and will be compatible with future innovations from both companies.
“Hearing loss takes many forms, and in some cases, multiple technologies are required for the best outcome of the patient,” said Mr Brandon Sawalich, president and CEO of Starkey.
“Today, two global tech leaders are combining world-class innovations to connect more people back to the things they love most. Partnering with MED-EL reflects our shared commitment to delivering excellence without exception.”
Audiologist Ms Dawn Rollings, managing director of Starkey Hearing Technologies, ANZ, said: “Hearing loss affects individuals in diverse ways, and often the best outcomes come from integrating multiple technologies.
“This collaboration between two global leaders represents a powerful step forward in reconnecting people with the sounds and experiences they cherish most. Our partnership with MED-EL highlights a shared passion for innovation and an unwavering commitment to excellence in hearing health.”
Dr Ingeborg Hochmair, co-founder and CEO of MED-EL, added: “By uniting two leading technologies, we are delivering a global solution that gives bimodal users effortless connectivity, clearer sound, and greater control in their daily lives.
“Our shared goal is simple: to make it easier for people everywhere to hear, communicate, and engage with the world – using the most advanced technology available.”
The companies said the collaboration reflected a shared commitment to patient-first innovation, personalised care, and expanding access to the latest in hearing technology available to users worldwide.
For more information, visit www.starkey.com or www.medel.com.
